SELARL LA GRANDE PHARMACIE DES MINIMES : revenue, balance sheet and financial ratios

SELARL LA GRANDE PHARMACIE DES MINIMES is a French company founded 13 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in LE MANS (72000), this company of category PME shows in 2022 a revenue of 8.9 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SELARL LA GRANDE PHARMACIE DES MINIMES (SIREN 752046706)
Indicator 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Revenue N/C N/C N/C 8 913 125 € N/C N/C N/C N/C 6 379 147 € 6 060 540 €
Net income 155 644 € 244 136 € 252 018 € 361 197 € 223 391 € 258 721 € 255 626 € 142 595 € 329 446 € 325 625 €
EBITDA N/C N/C N/C 706 074 € N/C N/C N/C N/C 641 701 € 538 470 €
Net margin N/C N/C N/C 4.1% N/C N/C N/C N/C 5.2% 5.4%

Revenue and income statement

In 2025, SELARL LA GRANDE PHARMACIE DES MINIMES generates positive net income of 156 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2025: 326 k€ -> 156 k€.

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

155 644 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 78%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 40%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

77.671%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

40.484%

Solvency indicators evolution
SELARL LA GRANDE PHARMACIE DES MINIMES

Sector positioning

Debt ratio
77.67 2025
2023
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Average

In 2025, the debt ratio of SELARL LA GRANDE PHARMACI... (77.67) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
40.48% 2025
2023
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Average

In 2025, the financial autonomy of SELARL LA GRANDE PHARMACI... (40.5%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2025) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2025) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2025) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2025) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
SELARL LA GRANDE PHARMACIE DES MINIMES

Positioning of SELARL LA GRANDE PHARMACIE DES MINIMES in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 277 transactions of similar company sales in 2025, the value of SELARL LA GRANDE PHARMACIE DES MINIMES is estimated at 2 472 423 € (range 1 677 798€ - 3 879 572€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2025
277 transactions
1677k€ 2472k€ 3879k€
2 472 423 € Range: 1 677 798€ - 3 879 572€
NAF 5 année 2025

Valuation method used

Net Income Multiple
155 644 € × 15.9x = 2 472 423 €
Range: 1 677 798€ - 3 879 573€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELARL LA GRANDE PHARMACIE DES MINIMES with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SELARL LA GRANDE PHARMACIE DES MINIMES

What is the revenue of SELARL LA GRANDE PHARMACIE DES MINIMES ?

The revenue of SELARL LA GRANDE PHARMACIE DES MINIMES in 2022 is 8.9 M€.

Is SELARL LA GRANDE PHARMACIE DES MINIMES profitable?

Yes, SELARL LA GRANDE PHARMACIE DES MINIMES generated a net profit of 156 k€ in 2025.

Where is the headquarters of SELARL LA GRANDE PHARMACIE DES MINIMES ?

The headquarters of SELARL LA GRANDE PHARMACIE DES MINIMES is located in LE MANS (72000), in the department Sarthe.

Where to find the tax return of SELARL LA GRANDE PHARMACIE DES MINIMES ?

The tax return of SELARL LA GRANDE PHARMACIE DES MINIMES is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELARL LA GRANDE PHARMACIE DES MINIMES operate?

SELARL LA GRANDE PHARMACIE DES MINIMES operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.